Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Errol Desouza Insider Profile
4 Followers
Errol Desouza, CEO, Director at Albireo Pharma, holds 41.25K shares in Alector (Ticker: ALEC), holds 30.00K shares in Cyclerion Therapeutics (Ticker: CYCN), holds 64.44K shares in Royalty Pharma (Ticker: RPRX).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-25.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Errol Desouza holds in companies
Most Profitable Insider Trade
Stock:
Albireo Pharma
(ALBO)
(ALBO)
Rating:Informative Buy
Date:Nov 11, 2011 - Nov 11, 2012
Return:-3.50%
The most profitable trade made by Errol Desouza
Errol Desouza's Trading History
Albireo Pharma
Oct 02, 2015
―
Uninformative Sell
19.13K
$7.04M
Royalty Pharma
Jun 26, 2023
Director
Uninformative Buy
―
$1.81M
Cyclerion Therapeutics
Dec 04, 2023
Director
Uninformative Buy
―
$91.20K
Alector
Mar 21, 2024
Director
Uninformative Buy
―
$217.80K
Gyre Therapeutics
Oct 05, 2021
Director
Uninformative Buy
―
$413.04K
Idexx Laboratories
Apr 30, 2009
Director
Uninformative Buy
12.50K
$3.41M
Palatin Technologies
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Errol Desouza's performance on stock
You May Also Like
Errol Desouza insider profile FAQ
What is the percentage of profitable transactions made by Errol Desouza?
The percentage of profitable transactions made by Errol Desouza is 0%.
What is the average return per transaction made by Errol Desouza?
The average return per transaction made by Errol Desouza is -25.10%.
What stocks does Errol Desouza hold?
Errol Desouza holds: ALBO, RPRX, CYCN, ALEC, GYRE, IDXX, PTN stocks.
What was Errol Desouza’s latest transaction?
Errol Desouza latest transaction was an Uninformative Buy of ―.
What was Errol Desouza's most profitable transaction?
Errol Desouza’s most profitable transaction was an Informative Buy of ALBO stock on November 11, 2011. The return on the trade was -3.50%.
What is Errol Desouza's role in Albireo Pharma?
Errol Desouza's role in Albireo Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.